Caris Life Sciences, Inc. (CAI)
US — Healthcare Sector
Automate Your Wheel Strategy on CAI
With Tiblio's Option Bot, you can configure your own wheel strategy including CAI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CAI
- Rev/Share 4.6568
- Book/Share 6.9764
- PB 4.9339
- Debt/Equity 0.9251
- CurrentRatio 9.2406
- ROIC -0.0458
- MktCap 9681582082.0
- FreeCF/Share -0.4332
- PFCF -344.234
- PE -12.8151
- Debt/Assets 0.4387
- DivYield 0
- ROE 0.1624
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | CAI | BofA Securities | -- | Buy | -- | $31 | July 14, 2025 |
| Initiation | CAI | BTIG Research | -- | Buy | -- | $38 | July 14, 2025 |
| Initiation | CAI | Citigroup | -- | Buy | -- | $34 | July 14, 2025 |
| Initiation | CAI | Evercore ISI | -- | Outperform | -- | $33 | July 14, 2025 |
| Initiation | CAI | Guggenheim | -- | Buy | -- | $32 | July 14, 2025 |
| Initiation | CAI | JP Morgan | -- | Overweight | -- | $31 | July 14, 2025 |
| Initiation | CAI | TD Cowen | -- | Buy | -- | $32 | July 14, 2025 |
| Initiation | CAI | Wolfe Research | -- | Outperform | -- | $32 | July 14, 2025 |
News
U.S. IPO Weekly Recap: Sizable Precision Medicine And Insurance IPOs Raise A Combined $902 Million
ALAB,
ARM,
AXINU,
CAI,
EGG,
IPO,
IPOS,
JCAP,
KGF,
MENS,
PACHU,
SLDE
Published: June 22, 2025 by: Seeking Alpha
Sentiment: Positive
Published: June 22, 2025 by: Seeking Alpha
Sentiment: Positive
A handful of IPOs and blank checks priced in the short holiday week, led by two sizable issuers. Two smaller IPOs also priced this past week. One IPO is currently scheduled to list in the week ahead, although some small names may also join the calendar throughout the week.
Read More
About Caris Life Sciences, Inc. (CAI)
- IPO Date 2025-06-18
- Website https://www.carislifesciences.com
- Industry Biotechnology
- CEO David Dean Halbert
- Employees 1769
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.